Key Insights into the Kidney Biopsy Market: Trends, Growth Rate, and Opportunities Through 2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What External and Internal Drivers Are Contributing to the Growth of theKidney Biopsy Market?
The kidney biopsy market is predicted to grow due to an increased prevalence of renal cancer. This type of cancer, defined by unregulated development of anomalous kidney cells, can be attributed to lifestyle transformations, exposure to environmental toxins, and improved detection methods leading to more diagnoses. A kidney biopsy is a crucial tool in the diagnosis and management of renal cancer. It verifies the existence of malignant cells and classifies the cancer grade. In addition, it aids in creating a treatment plan, monitoring its effectiveness, and offering prognosis-related information. For example, Cancer Research UK, a cancer research institution based in the UK, anticipates that new renal cancer cases will rise from roughly 16,300 in 2023 to an estimated 21,900 in 2025. Hence, the escalating occurrence of renal cancer is fuelling the expansion of the kidney biopsy market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp
#How Will the CAGR of the Kidney Biopsy Market Influence Its Overall Growth by 2034?
In the past few years, the kidney biopsy market has seen significant growth. The market, which was valued at $2.14 billion in 2024, is projected to climb to $2.27 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.8%. The historical growth rate is attributed to a rise in chronic kidney diseases, an increase in consciousness about early diagnoses, a booming elderly population, expansion of the healthcare infrastructure, improved government-led initiatives for handling kidney diseases, and heightened awareness about renal health.
Over the coming years, a significant surge is anticipated in the kidney biopsy market size, predicted to balloon to $2.8 billion by 2029, with an established compound annual growth rate (CAGR) of 5.4%. This projected expansion over the forecast period is linked to the growing incidence of kidney-related diseases, an increase in healthcare spending, heightened awareness for preventive early diagnosis, a burgeoning elderly population, and a growing preference for minimally invasive procedures, along with surges in research initiatives. Key trends during this forecast period encompass technological breakthroughs in biopsy procedures, a growing preference for minimally invasive processes, new developments in imaging technology, the incorporation of artificial intelligence for enhanced precision, and innovative changes in biopsy device technology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458
Which Upcoming Market Trends and Innovations Are Set to Influence theKidney Biopsy Market’s Path Forward?
Prominent businesses in the kidney biopsy market are making strides in innovation through the incorporation of artificial intelligence (AI) to heighten diagnostic precision, streamline protocols, and boost patient outcomes. AI plays a crucial role in strengthening kidney biopsy procedures through improved image interpretation, diagnostic assistance, help in devising treatment plans, predictive analysis provision, and fostering advancements in kidney disease research. For instance, the NephroPath platform was introduced in March 2024 by Aiosyn, a software company established in the Netherlands. By using computational pathology algorithms, the NephroPath platform can break down histological biomarkers in kidney biopsies—such activities include tissue type identification, interstitial fibrosis measurement, and precise glomeruli accounting and assessment. This AI-guided analysis maintains consistent, thorough, and repeatable scoring of renal pathology biomarkers, effectively addressing the limitations of traditional scoring methods and observer bias.
Who Are the Dominant Market Players Pushing the Boundaries of theKidney Biopsy Market?
Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report
What Are the Core Segments of the Kidney Biopsy Market, and How Do They Contribute to Growth?
The kidney biopsy market covered in this report is segmented –
1) By Type: Percutaneous Biopsy, Surgical Biopsy
2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria
3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users
Subsegments:
1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy
2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp
What Regions Are Dominating the Kidney Biopsy Market Growth?
North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Kidney Biopsy Market 2025, By The Business Research Company:
Diabetic Kidney Disease Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report
Kidney Disease Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report
Kidney Cancer Diagnostics And Therapeutics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
